CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Egis Gyogyszergyar Zrt is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Egis Gyogyszergyar Zrt
Kereszturi ut 30-38.
Phone: +36 18035555p:+36 18035555 BUDAPEST, 1106  Hungary Ticker: EGISEGIS
Business Summary
Egis Gyogyszergyar Zrt (EGIS) is a Hungary-based company engaged in the pharmaceutical industry. Its core activities are the production of pharmaceuticals and active pharmaceutical ingredients, research and development, sales of finished products and active pharmaceutical ingredients. Its product range includes tablets, ointments, suppositories, solutions, syrups and aerosols. EGIS is involved in research activities aimed at the development of generic pharmaceutical products. The operations are located in three production facilities, two in Budapest and one in Kormend of Hungary. As of December 31, 2012, the Company operated 10 wholly owned subsidiaries based in Hungary, Poland, Slovakia, the Czech Republic, Romania, Bulgaria, Turkey, the United Kingdom and the Russian Federation. The Company’s major shareholder was ATP (Servier), with a 50.91% stake in the capital.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 IRA CQ
Score		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-Yes----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/20139/30/2012Yes----

Industries
SIC Code Description
2833 Medicinal chemicals and botanical products
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Independent Chairman of the Board Jean-PhilippeSeta 1/29/1996 1/29/1996
Independent Chairman of the Supervisory Board AndorKovacs 12/31/1991 12/31/1991
Chief Executive Officer, Director IstvanHodasz 9/30/2009 1/16/2006
11 additional Officers and Directors records available in full report.

Business Names
Business Name
EGIS
Egis Gyogyszergyar NyRt.
Egis Gyogyszergyar Rt.
Egis Pharmaceuticals Limited

General Information
Number of Employees: 3,966 (As of 6/30/2013)
Outstanding Shares: 7,785,715 (As of 9/30/2013)
Shareholders: 1,269
Stock Exchange: BDP
Fax Number: +36 18035529


Copyright © 2020 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, March 28, 2020